SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-004830
Filing Date
2004-10-19
Accepted
2004-10-19 10:18:05
Documents
2
Period of Report
2004-10-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b52205tke8vk.htm 8-K 12399
2 EX-99.1 PRESS RELEASE, DATED OCTOBER 15, 2004 b52205tkexv99w1.htm EX-99.1 7290
  Complete submission text file 0000950135-04-004830.txt   21402
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 041084406
SIC: 2836 Biological Products, (No Diagnostic Substances)